$277.20
0.980.35%
Last update: Nov 9, 9:24 AM
Johnson & Johnson
JNJNYSE
Johnson & Johnson (JNJ) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Johnson & Johnson (JNJ) last issued guidance on October 13, 2026 for fiscal year 2026. The company guided earnings per share in the range of $11.05 - $11.15, compared to a consensus EPS estimate of $11.1. Johnson & Johnson also guided revenue in the range of $101B - $101.4B for the period.
Compared to prior guidance, Johnson & Johnson maintained its EPS outlook from a previous range of $10.96 - $11.11. On the revenue side, the company maintained its revenue forecast from a prior range of $100.8B - $101.4B.
Johnson & Johnson has issued 20 guidance updates between January 24, 2023 and October 13, 2026. During this period, the company raised its outlook 5 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.53 | $2.85 | $2.67 | $2.47 |
| Actual | $2.59 | $2.90 | $2.70 | $2.46 |
| Surprise | +2.37% | +1.75% | +1.12% | -0.40% |
| Revenue | ||||
| Estimate | $25.39B | $25.05B | $23.54B | $24.15B |
| Actual | $25.40B | $25.31B | $24.06B | $24.56B |
| Surprise | +0.02% | +1.04% | +2.20% | +1.71% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.91 | $2.68 | $2.95 | $2.79 |
| Revenue | ||||
| Consensus | $26.41B | $25.50B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 13, 2026 | $2.59 | $2.53 | 2.37 % |
| Q2 | Jul 15, 2026 | $2.90 | $2.85 | 1.75 % |
| Q1 | Apr 14, 2026 | $2.70 | $2.67 | 1.12 % |
| Q4 | Jan 21, 2026 | $2.46 | $2.47 | -0.40 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 13, 2026 | $25.40B | $25.39B | 0.02 % |
| Q2 | Jul 15, 2026 | $25.31B | $25.05B | 1.04 % |
| Q1 | Apr 14, 2026 | $24.06B | $23.54B | 2.20 % |
| Q4 | Jan 21, 2026 | $24.56B | $24.15B | 1.71 % |
